AOAC approvals benefit the cannabis industry by providing you third party independent validation to authenticate package insert claims and the test kit performance providing confidence and brand ...
Sixty-three patients with advanced EGFR-mutant lung cancer at 7 Canadian centers, who were being screened for the ASTRIS trial (ClinicalTrials.gov identifier: NCT02474355), participated in this ...
PLEASANTON, Calif.--(BUSINESS WIRE)--DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that the company has formed strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results